Literature DB >> 15270651

Bacterial viruses as human vaccines?

Jason R Clark1, John B March.   

Abstract

Bacteriophages (or phages) are viruses of bacteria, consisting of nucleic acid packaged within a protein coat. In eukaryotic hosts, phages are unable to replicate and in the absence of a suitable prokaryotic host, behave as inert particulate antigens. In recent years, work has shown that whole phage particles can be used to deliver vaccines in the form of immunogenic peptides attached to modified phage coat proteins or as delivery vehicles for DNA vaccines, by incorporating a eukaryotic promoter-driven vaccine gene within their genome. While both approaches are promising by themselves, in future there is also the exciting possibility of creating a hybrid phage combining both components to create phage that are cheap, easy and rapid to produce and that deliver both protein and DNA vaccines via the oral route in the same construct.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15270651     DOI: 10.1586/14760584.3.4.463

Source DB:  PubMed          Journal:  Expert Rev Vaccines        ISSN: 1476-0584            Impact factor:   5.217


  18 in total

1.  Phage library screening for the rapid identification and in vivo testing of candidate genes for a DNA vaccine against Mycoplasma mycoides subsp. mycoides small colony biotype.

Authors:  John B March; Catherine D Jepson; Jason R Clark; Makrina Totsika; Michael J Calcutt
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

Review 2.  Bacteriophages and its applications: an overview.

Authors:  Sonika Sharma; Soumya Chatterjee; Sibnarayan Datta; Rishika Prasad; Dharmendra Dubey; Rajesh Kumar Prasad; Mohan G Vairale
Journal:  Folia Microbiol (Praha)       Date:  2016-10-08       Impact factor: 2.099

Review 3.  Phage Therapy in the Era of Synthetic Biology.

Authors:  E Magda Barbu; Kyle C Cady; Bolyn Hubby
Journal:  Cold Spring Harb Perspect Biol       Date:  2016-10-03       Impact factor: 10.005

Review 4.  Therapeutic and prophylactic applications of bacteriophage components in modern medicine.

Authors:  Sankar Adhya; Carl R Merril; Biswajit Biswas
Journal:  Cold Spring Harb Perspect Med       Date:  2014-01-01       Impact factor: 6.915

Review 5.  Bacteriophages and phage-inspired nanocarriers for targeted delivery of therapeutic cargos.

Authors:  Mahdi Karimi; Hamed Mirshekari; Seyed Masoud Moosavi Basri; Sajad Bahrami; Mohsen Moghoofei; Michael R Hamblin
Journal:  Adv Drug Deliv Rev       Date:  2016-03-17       Impact factor: 15.470

Review 6.  Bacteriophages and their applications in the diagnosis and treatment of hepatitis B virus infection.

Authors:  Babak Bakhshinejad; Majid Sadeghizadeh
Journal:  World J Gastroenterol       Date:  2014-09-07       Impact factor: 5.742

Review 7.  Bacteriophages and their implications on future biotechnology: a review.

Authors:  Irshad Ul Haq; Waqas Nasir Chaudhry; Maha Nadeem Akhtar; Saadia Andleeb; Ishtiaq Qadri
Journal:  Virol J       Date:  2012-01-10       Impact factor: 4.099

Review 8.  Phages and HIV-1: from display to interplay.

Authors:  Sylvie Delhalle; Jean-Claude Schmit; Andy Chevigné
Journal:  Int J Mol Sci       Date:  2012-04-13       Impact factor: 6.208

9.  Pulmonary bacteriophage therapy on Pseudomonas aeruginosa cystic fibrosis strains: first steps towards treatment and prevention.

Authors:  Eric Morello; Emilie Saussereau; Damien Maura; Michel Huerre; Lhousseine Touqui; Laurent Debarbieux
Journal:  PLoS One       Date:  2011-02-15       Impact factor: 3.240

10.  Cry protein crystals: a novel platform for protein delivery.

Authors:  Manoj S Nair; Marianne M Lee; Astrid Bonnegarde-Bernard; Julie A Wallace; Donald H Dean; Michael C Ostrowski; Richard W Burry; Prosper N Boyaka; Michael K Chan
Journal:  PLoS One       Date:  2015-06-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.